Related Experiment Videos
Reduced IQGAP2 promotes esophageal squamous cell carcinoma by regulating MEK/ERK MAPK pathway
1Department of Gastroenterology, The Fifth People's Hospital of Wujiang District, Suzhou, Jiangsu, China.
Background:
IQ motif-containing GTPase activating protein 2 (IQGAP2) has been identified as a tumor suppressor in various cancers; however, its role in esophageal squamous cell carcinoma (ESCC) remains unclear.
Methods:
We analyzed IQGAP2 expression in tumor tissues from 236 ESCC patients using RNA sequencing and validated the findings with qPCR. EC9706 ESCC cell lines with IQGAP2 overexpression and knockdown were established via lentiviral transfection and selection. Cell proliferation was assessed using the CCK-8 assay, and activation of the MEK/ERK MAPK pathway was evaluated by Western blotting.
Results:
IQGAP2 expression was significantly decreased in tumor samples from ESCC patients. Overexpression of IQGAP2 markedly inhibited proliferation of ES9706 cells, whereas knockdown of IQGAP2 promoted cell proliferation. Mechanistically, decreased IQGAP2 expression enhances ESCC cell proliferation by activating the MEK/ERK MAPK signaling pathway.
Conclusion:
Our findings highlight IQGAP2 as a potential therapeutic target in ESCC, warranting further investigation for the development of effective treatments.
Insights
IQ motif-containing GTPase activating protein 2 (IQGAP2) is decreased in esophageal squamous cell carcinoma (ESCC). Lower IQGAP2 levels promote ESCC cell proliferation by activating the MEK/ERK MAPK pathway, suggesting IQGAP2 as a therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- IQ motif-containing GTPase activating protein 2 (IQGAP2) functions as a tumor suppressor in multiple cancer types.
- The specific role of IQGAP2 in esophageal squamous cell carcinoma (ESCC) pathogenesis is not well-defined.
Purpose of the Study:
- To investigate the expression levels of IQGAP2 in ESCC tissues.
- To elucidate the functional role of IQGAP2 in ESCC cell proliferation.
- To explore the underlying molecular mechanisms, particularly the MEK/ERK MAPK pathway.
Main Methods:
- IQGAP2 expression analysis in 236 ESCC patient tumor tissues via RNA sequencing and qPCR.
- Establishment of ESCC cell lines with IQGAP2 overexpression and knockdown using lentiviral methods.
- Assessment of cell proliferation using CCK-8 assays and MEK/ERK MAPK pathway activation via Western blotting.
Main Results:
- IQGAP2 expression was significantly downregulated in ESCC tumor samples compared to normal tissues.
- IQGAP2 overexpression inhibited ESCC cell proliferation, while IQGAP2 knockdown promoted it.
- Reduced IQGAP2 expression was found to enhance ESCC cell proliferation through activation of the MEK/ERK MAPK signaling pathway.
Conclusions:
- IQGAP2 acts as a tumor suppressor in ESCC.
- The downregulation of IQGAP2 contributes to ESCC progression via the MEK/ERK MAPK pathway.
- IQGAP2 represents a potential therapeutic target for ESCC treatment.
Related Concept Videos
MAPK Signaling Cascades
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...